FIBIN Inhibitors
NFFIBIN inhibitors encompass a varied class of chemical compounds that are known to interfere with specific cellular signaling pathways which could potentially result in the inhibition of FIBIN activity, despite the lack of direct inhibitors targeting FIBIN specifically. These inhibitors target pathways such as tyrosine phosphatase activity, PI3K/Akt signaling, p38 MAPK, ERK1/2, mTOR, JNK, Src family kinases, and the NF-kappaB pathway. The mechanisms of action for these inhibitors are diverse, but they all converge on the potential to alter FIBIN function indirectly through their effects on these signaling pathways.
For instance, Sodium orthovanadate, by inhibiting protein tyrosine phosphatases, could maintain a phosphorylated state of proteins that may need to be dephosphorylated for FIBIN to function properly. Similarly, LY294002 and Wortmannin, as PI3K inhibitors, could prevent the activation of the PI3K/Akt pathway, which might be essential for FIBIN's activity. On the other hand, compounds like SB203580, PD98059, and U0126, which inhibit various MAP kinases, could affect FIBIN function if it is regulated by MAPK-mediated signaling. In the realm of protein synthesis, Rapamycin's inhibition of the mTOR pathway could lead to reduced translation of proteins, potentially affecting those involved in regulating FIBIN. Bortezomib, by disrupting protein degradation, could result in the accumulation of regulatory proteins that may suppress FIBIN activity. Sp600125 and U0126, as inhibitors of JNK and MEK respectively, could decrease the activation of transcription factors and gene expression relevant to FIBIN regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
Sodium orthovanadate is a general tyrosine phosphatase inhibitor. By inhibiting tyrosine phosphatases, it can maintain proteins in a phosphorylated state. Phosphorylation can regulate the activity of many proteins, including FIBIN. If FIBIN is functionally regulated by phosphorylation, its activity could be reduced as a result of aberrant phosphatase inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that blocks the PI3K/Akt signaling pathway. This pathway is involved in various cellular processes, including cell survival and proliferation. Inhibition of PI3K could lead to reduced phosphorylation and activation of downstream targets, which may indirectly inhibit the functional activity of FIBIN if it is a downstream effector of this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. The p38 MAPK pathway is involved in stress responses and cytokine production. The inhibition of p38 MAPK can lead to decreased activation of downstream transcription factors and substrates, potentially reducing the functional activity of FIBIN if it is regulated through this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor that blocks the activity of ERK1/2. Since the ERK pathway is involved in regulating various cellular functions, inhibition of MEK could result in decreased ERK-mediated phosphorylation of target proteins. If FIBIN activity is contingent on ERK signaling, its functional activity could be indirectly reduced by PD98059. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is an irreversible inhibitor of PI3K, which impairs the PI3K/Akt pathway. By disrupting this pathway, wortmannin can lead to reduced cellular proliferation, growth, and survival. If FIBIN is a part of the cellular processes modulated by the PI3K/Akt pathway, its activity could be indirectly inhibited by wortmannin. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an mTOR inhibitor and by inhibiting mTOR, it disrupts the mTORC1 and mTORC2 complexes. These complexes are involved in protein synthesis and actin cytoskeleton organization. Inhibition of mTOR could result in decreased protein synthesis and altered cytoskeletal dynamics, which could indirectly inhibit the functional activity of FIBIN if it relies on these cellular processes for its activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor that prevents the degradation of ubiquitinated proteins, leading to cellular stress and apoptosis. If FIBIN's functional activity is regulated via ubiquitin-proteasome pathways, its activity might be indirectly inhibited by the accumulation of proteins that would otherwise modulate its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Sp600125 is an inhibitor of JNK, a kinase involved in the regulation of apoptosis, cell differentiation, and inflammation. By inhibiting JNK, Sp600125 could lead to altered transcription factor activity and gene expression. If FIBIN is regulated by JNK-mediated signaling events, its activity could be indirectly reduced by Sp600125. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which interrupts the activation of the ERK1/2 pathway. The ERK pathway influences cellular proliferation, differentiation, and survival. If FIBIN is modulated by or dependent on the ERK signaling for its function, U0126 could indirectly inhibit its functional activity by inhibiting this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is a Src family kinase inhibitor. Src kinases are involved in signal transduction pathways that regulate various cellular processes, including cell growth and differentiation. If FIBIN's activity is mediated by Src kinase signaling, PP2 could indirectly inhibit its functional activity by blocking this pathway. | ||||||